The Drug and Medical Device Committee is the preeminent organization for attorneys who represent the manufacturers of pharmaceuticals, medical devices, biologics and other products created to provide health benefits to consumers. The Drug and Medical Device Committee is one of DRI's largest committees, and there are endless opportunities to become involved for new practitioners to seasoned attorneys, whether they are in a firm, in-house, or risk management.
There is no better way to get involved in our committee than to attend our annual seminar, which will be held on May 15-16, 2014 at the Washington Renaissance in our nation's capital. This year’s program will offer a variety of presentations, including a panel discussion about warning in a digital age with the Director of the FDA Center for Drug Evaluation and Research, a trial skills demonstration, a panel discussion with a state and a federal judge coordinating parallel proceedings, and litigation insights from leading defenders of drug and device cases. In addition to the outstanding main stage program, we will also host our annual Young Lawyers Blockbuster, the In-house Counsel Breakout (available only to in-house counsel), our annual Diversity Luncheon, and a Service Project, which will offer opportunities to service a Washington food bank. Lastly, don't miss out on the numerous networking opportunities that are held in association with the seminar.
In addition to our seminar, our committee plans and presents webcasts on the most up-to-date topics for drug and device defense counsel. On Tuesday, April 22, 2014, at 2:00 p.m. EST/11:00 a.m. PST, our Committee (in conjunction with the Electronic Discovery Committee) will present a Webcast entitled Hot Topics: Avoiding Sanctions - Litigation Holds and E-Discovery in 2014. The Webcast is 90 minutes in length and provides an excellent opportunity for CLE. Most states allow CLE for web based programs. Our two excellent presenters are Wendy Butler Curtis (Orrick in Washington, DC) and Jason Lichter (Pepper Hamilton in NYC). Registration fee is $150 per office site.
Rx For The Defense
The Committee newsletter, Rx For The Defense is published on a quarterly basis. The newsletter is distributed electronically and is available to all members of the Drug and Medical Device Committee. Our most recent newsletter was published in March 2014. Please e-mail the Committee’s Newsletter Editor, Archie Reeves, if you are interested in contributing to an upcoming edition. The deadline for our next newsletter is June 9, 2014.
Dedicated Issue of For The Defense
The Committee continues its tradition of coordinating an excellent collection of drug and medical device-related articles for publication in For The Defense. Please e-mail the Committee’s editor for this issue, Anne Talcott, if you are interested in contributing to an upcoming edition. The deadline for submitting proposed articles to Anne is June 1, 2014.
On September 30, 2014, the Committee will host a Litigation Primer for lawyers who are in their first three years of practice in this area. The Primer will be held at Sidley & Austin's Chicago office. This one-day program brings together many of the most outstanding trial lawyers and in-house counsel in the country to share their experiences with younger lawyers. Topics include the FDA regulatory system, defenses in drug and medical device litigation, medical causation, the law of failure to warn claims and a number of other key topics for the new practitioner.
There are numerous other opportunities to become involved in the Committee. Please contact Jim Rogers or Carter Thompson if you are interested in becoming active in the Committee.